Titan Pharmaceuticals

-$0.05 (-2.16%) As of 6:07 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TTNP and other ETFs, options, and stocks.

About TTNP

Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.

CEO
Sunil Bhonsle, MBA
Employees
12
Headquarters
South San Francisco, California
Founded
1992

TTNP Key Statistics

Market Cap
24.11M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
71.56K
High Today
$2.30
Low Today
$2.24
Open Price
$2.30
Volume
48.67K
52 Week High
$10.17
52 Week Low
$2.15

TTNP Earnings

-$0.96
-$0.64
-$0.32
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure